Loading market dashboard
Terns Pharmaceuticals, Inc.
TERNHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Terns Pharmaceuticals, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $220.26M | $220.26M - $220.26M | $132.15M | -$0.32 | 2 |
| Dec 2029 | $60.10M | $60.10M - $60.10M | $36.06M | -$1.51 | 2 |
| Dec 2028 | $11.85M | $11.85M - $11.85M | $7.11M | -$1.81 | 5 |
| Dec 2027 | $5.77M | $5.77M - $5.77M | $3.46M | -$1.43 | 6 |
| Dec 2026 | $960.0K | $960.0K - $960.0K | $576.0K | -$1.156 | 7 |
| Dec 2025 | $1.71M | $1.71M - $1.71M | $1.03M | -$1.062 | 7 |
| Dec 2024 | $1.95M | $1.95M - $1.95M | $1.17M | -$1.195 | 8 |